Protracted late infantile ceroid lipofuscinosis due to TPP1 mutations: Clinical, molecular and biochemical characterization in three sibs

Raffaella Di Giacopo, Luciano Cianetti, Viviana Caputo, Ilaria La Torraca, Fiorella Piemonte, Andrea Ciolfi, Simona Petrucci, Claudio Carta, Paolo Mariotti, Vincenzo Leuzzi, Enza Maria Valente, Adele D'Amico, Annarita Bentivoglio, Enrico Bertini, Marco Tartaglia, Giuseppe Zampino

Research output: Contribution to journalArticle

Abstract

Abstract Objective This work investigated the molecular cause responsible for a late-onset parkinsonism-dystonia phenotype in three Italian siblings, and clinically characterize this condition. Methods Extensive neurophysiological and neuroradiological exams were performed on the three sibs. Most frequent late-onset metabolic diseases were ruled out through laboratory and biochemical analyses. A whole exome sequencing (WES) approach was used to identify the molecular cause underlying this condition. Results and conclusions Peculiar neurologic phenotype was characterized by dystonia-parkinsonism, cognitive impairment, gait ataxia and apraxia, pyramidal signs. WES analysis allowed the identification of a compound heterozygosity for two nucleotide substitutions (c.1340G>A, p.R447H; c.790C>T, p.Q264X) affecting the TPP1 gene in the three affected siblings. Biochemical analyses demonstrated abrogated TPP1 catalytic activity in primary skin fibroblasts, but revealed residual activity in leukocytes. Our findings document that late infantile neuronal ceroid lipofuscinosis (CLN2), which is caused by TPP1 gene mutations, should be considered in the differential diagnosis of autosomal recessive dystonia-parkinsonism syndromes. The availability of enzyme replacement therapy and other therapeutic approaches for ceroid lipofuscinoses emphasizes the value of reaching an early diagnosis in patients with atypical and milder presentation of these disorders.

Original languageEnglish
Article number13806
Pages (from-to)65-71
Number of pages7
JournalJournal of the Neurological Sciences
Volume356
Issue number1-2
DOIs
Publication statusPublished - Sep 15 2015

Fingerprint

Ceroid
Dystonia
Parkinsonian Disorders
Exome
Mutation
Gait Apraxia
Siblings
Gait Ataxia
Neuronal Ceroid-Lipofuscinoses
Enzyme Replacement Therapy
Phenotype
Metabolic Diseases
Nervous System
Genes
Early Diagnosis
Leukocytes
Differential Diagnosis
Nucleotides
Fibroblasts
Skin

Keywords

  • Autosomal recessive Parkinson-dystonia
  • Differential diagnoses of late infantile parkinsonism
  • Late infantile ceroid lipofuscinoses
  • Protracted CLN2 disease
  • TPP1 gene mutations
  • Whole exome sequencing

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Protracted late infantile ceroid lipofuscinosis due to TPP1 mutations : Clinical, molecular and biochemical characterization in three sibs. / Di Giacopo, Raffaella; Cianetti, Luciano; Caputo, Viviana; La Torraca, Ilaria; Piemonte, Fiorella; Ciolfi, Andrea; Petrucci, Simona; Carta, Claudio; Mariotti, Paolo; Leuzzi, Vincenzo; Valente, Enza Maria; D'Amico, Adele; Bentivoglio, Annarita; Bertini, Enrico; Tartaglia, Marco; Zampino, Giuseppe.

In: Journal of the Neurological Sciences, Vol. 356, No. 1-2, 13806, 15.09.2015, p. 65-71.

Research output: Contribution to journalArticle

Di Giacopo, R, Cianetti, L, Caputo, V, La Torraca, I, Piemonte, F, Ciolfi, A, Petrucci, S, Carta, C, Mariotti, P, Leuzzi, V, Valente, EM, D'Amico, A, Bentivoglio, A, Bertini, E, Tartaglia, M & Zampino, G 2015, 'Protracted late infantile ceroid lipofuscinosis due to TPP1 mutations: Clinical, molecular and biochemical characterization in three sibs', Journal of the Neurological Sciences, vol. 356, no. 1-2, 13806, pp. 65-71. https://doi.org/10.1016/j.jns.2015.05.021
Di Giacopo, Raffaella ; Cianetti, Luciano ; Caputo, Viviana ; La Torraca, Ilaria ; Piemonte, Fiorella ; Ciolfi, Andrea ; Petrucci, Simona ; Carta, Claudio ; Mariotti, Paolo ; Leuzzi, Vincenzo ; Valente, Enza Maria ; D'Amico, Adele ; Bentivoglio, Annarita ; Bertini, Enrico ; Tartaglia, Marco ; Zampino, Giuseppe. / Protracted late infantile ceroid lipofuscinosis due to TPP1 mutations : Clinical, molecular and biochemical characterization in three sibs. In: Journal of the Neurological Sciences. 2015 ; Vol. 356, No. 1-2. pp. 65-71.
@article{69390f99710245728f5236c84598a179,
title = "Protracted late infantile ceroid lipofuscinosis due to TPP1 mutations: Clinical, molecular and biochemical characterization in three sibs",
abstract = "Abstract Objective This work investigated the molecular cause responsible for a late-onset parkinsonism-dystonia phenotype in three Italian siblings, and clinically characterize this condition. Methods Extensive neurophysiological and neuroradiological exams were performed on the three sibs. Most frequent late-onset metabolic diseases were ruled out through laboratory and biochemical analyses. A whole exome sequencing (WES) approach was used to identify the molecular cause underlying this condition. Results and conclusions Peculiar neurologic phenotype was characterized by dystonia-parkinsonism, cognitive impairment, gait ataxia and apraxia, pyramidal signs. WES analysis allowed the identification of a compound heterozygosity for two nucleotide substitutions (c.1340G>A, p.R447H; c.790C>T, p.Q264X) affecting the TPP1 gene in the three affected siblings. Biochemical analyses demonstrated abrogated TPP1 catalytic activity in primary skin fibroblasts, but revealed residual activity in leukocytes. Our findings document that late infantile neuronal ceroid lipofuscinosis (CLN2), which is caused by TPP1 gene mutations, should be considered in the differential diagnosis of autosomal recessive dystonia-parkinsonism syndromes. The availability of enzyme replacement therapy and other therapeutic approaches for ceroid lipofuscinoses emphasizes the value of reaching an early diagnosis in patients with atypical and milder presentation of these disorders.",
keywords = "Autosomal recessive Parkinson-dystonia, Differential diagnoses of late infantile parkinsonism, Late infantile ceroid lipofuscinoses, Protracted CLN2 disease, TPP1 gene mutations, Whole exome sequencing",
author = "{Di Giacopo}, Raffaella and Luciano Cianetti and Viviana Caputo and {La Torraca}, Ilaria and Fiorella Piemonte and Andrea Ciolfi and Simona Petrucci and Claudio Carta and Paolo Mariotti and Vincenzo Leuzzi and Valente, {Enza Maria} and Adele D'Amico and Annarita Bentivoglio and Enrico Bertini and Marco Tartaglia and Giuseppe Zampino",
year = "2015",
month = "9",
day = "15",
doi = "10.1016/j.jns.2015.05.021",
language = "English",
volume = "356",
pages = "65--71",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Protracted late infantile ceroid lipofuscinosis due to TPP1 mutations

T2 - Clinical, molecular and biochemical characterization in three sibs

AU - Di Giacopo, Raffaella

AU - Cianetti, Luciano

AU - Caputo, Viviana

AU - La Torraca, Ilaria

AU - Piemonte, Fiorella

AU - Ciolfi, Andrea

AU - Petrucci, Simona

AU - Carta, Claudio

AU - Mariotti, Paolo

AU - Leuzzi, Vincenzo

AU - Valente, Enza Maria

AU - D'Amico, Adele

AU - Bentivoglio, Annarita

AU - Bertini, Enrico

AU - Tartaglia, Marco

AU - Zampino, Giuseppe

PY - 2015/9/15

Y1 - 2015/9/15

N2 - Abstract Objective This work investigated the molecular cause responsible for a late-onset parkinsonism-dystonia phenotype in three Italian siblings, and clinically characterize this condition. Methods Extensive neurophysiological and neuroradiological exams were performed on the three sibs. Most frequent late-onset metabolic diseases were ruled out through laboratory and biochemical analyses. A whole exome sequencing (WES) approach was used to identify the molecular cause underlying this condition. Results and conclusions Peculiar neurologic phenotype was characterized by dystonia-parkinsonism, cognitive impairment, gait ataxia and apraxia, pyramidal signs. WES analysis allowed the identification of a compound heterozygosity for two nucleotide substitutions (c.1340G>A, p.R447H; c.790C>T, p.Q264X) affecting the TPP1 gene in the three affected siblings. Biochemical analyses demonstrated abrogated TPP1 catalytic activity in primary skin fibroblasts, but revealed residual activity in leukocytes. Our findings document that late infantile neuronal ceroid lipofuscinosis (CLN2), which is caused by TPP1 gene mutations, should be considered in the differential diagnosis of autosomal recessive dystonia-parkinsonism syndromes. The availability of enzyme replacement therapy and other therapeutic approaches for ceroid lipofuscinoses emphasizes the value of reaching an early diagnosis in patients with atypical and milder presentation of these disorders.

AB - Abstract Objective This work investigated the molecular cause responsible for a late-onset parkinsonism-dystonia phenotype in three Italian siblings, and clinically characterize this condition. Methods Extensive neurophysiological and neuroradiological exams were performed on the three sibs. Most frequent late-onset metabolic diseases were ruled out through laboratory and biochemical analyses. A whole exome sequencing (WES) approach was used to identify the molecular cause underlying this condition. Results and conclusions Peculiar neurologic phenotype was characterized by dystonia-parkinsonism, cognitive impairment, gait ataxia and apraxia, pyramidal signs. WES analysis allowed the identification of a compound heterozygosity for two nucleotide substitutions (c.1340G>A, p.R447H; c.790C>T, p.Q264X) affecting the TPP1 gene in the three affected siblings. Biochemical analyses demonstrated abrogated TPP1 catalytic activity in primary skin fibroblasts, but revealed residual activity in leukocytes. Our findings document that late infantile neuronal ceroid lipofuscinosis (CLN2), which is caused by TPP1 gene mutations, should be considered in the differential diagnosis of autosomal recessive dystonia-parkinsonism syndromes. The availability of enzyme replacement therapy and other therapeutic approaches for ceroid lipofuscinoses emphasizes the value of reaching an early diagnosis in patients with atypical and milder presentation of these disorders.

KW - Autosomal recessive Parkinson-dystonia

KW - Differential diagnoses of late infantile parkinsonism

KW - Late infantile ceroid lipofuscinoses

KW - Protracted CLN2 disease

KW - TPP1 gene mutations

KW - Whole exome sequencing

UR - http://www.scopus.com/inward/record.url?scp=84939261656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939261656&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2015.05.021

DO - 10.1016/j.jns.2015.05.021

M3 - Article

C2 - 26143525

AN - SCOPUS:84939261656

VL - 356

SP - 65

EP - 71

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

M1 - 13806

ER -